Helius Medical Technologies

Helius Medical Technologies

Neurotech company (Nasdaq: HSDT)

Helius Medical Technologiesについて

設立

2014

受信アドレス

United States

コミュニティ

Helius is a leading neurotechnology company in the medical device field, specializing in utilizing non-implantable platform technologies to treat neurological deficits, enhance the brain's compensatory abilities, and promote neuroplasticity, thereby improving the lives of patients with neurological disorders. The company has announced the establishment of the SOL Treasury.

チームメンバー

Dane C. Andreeff
Dane C. AndreeffPresident and Chief Executive Officer
Jeffrey S. Mathiesen
Jeffrey S. MathiesenChief Financial Officer

投資家

Pantera CapitalPantera Capital
Summer CapitalSummer Capital

資金調達の詳細

資金調達ラウンド金額評価額
Date
投資家
Post-IPO
¥73.83B
--
2025-09-14
Pantera CapitalPantera Capital*
Summer CapitalSummer Capital*